Normal function · from ai-gene-review (Q9Y561, commit 79fe13b38970) · AI-generated, not KB evidence

LRP12 is an 859-residue type-I single-pass plasma-membrane protein of the low-density-lipoprotein-receptor-related family. Its extracellular region contains two CUB domains and five LDL-receptor class A repeats, followed by one transmembrane helix and a long cytoplasmic tail. The tail binds α4 integrins and interferes with talin engagement, restraining integrin activation and balancing nascent-adhesion turnover and cell migration; it also interacts with RACK1, NMRK2/MIBP, and ZFYVE9/SARA. Mouse developmental studies link Lrp12 to neuronal arborization, migration, and cortical lamination. Two named human protein isoforms differ by a short N-terminal deletion. Noncoding CGG-repeat expansions in the LRP12 5-prime untranslated region cause oculopharyngodistal myopathy 1 and, at shorter pathogenic repeat lengths, amyotrophic lateral sclerosis 28.

At the plasma membrane, LRP12 binds the cytoplasmic tail of α4 integrins and restrains their activation by interfering with talin engagement, thereby balancing nascent-adhesion turnover and cell migration.
molecular function: integrin binding · directly involved in: negative regulation of integrin activation · locations: plasma membrane
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Amyotrophic Lateral Sclerosis causative
subtype: ALS28
scoped to subtype: ALS28
Oculopharyngodistal Myopathy causative
mechanism: Non-coding CGG-repeat expansion
subtype: OPDM1
scoped to subtype: OPDM1
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
oculopharyngodistal myopathy 1 MONDO:0020793 AD Moderate
2024-05-14

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.